Since Actemra (tocilizumab) hit the market in 2010, the U.S. Food and Drug Administration (FDA) has received at least 13,500 adverse event reports link to the drug, including 1,128 reports of death, according to a recent investigation by STAT. Actemra was approved to treat rheumatoid arthritis (RA) in 2010. In May 2017, the FDA approved Actemra for … [Read more...]